<DOC>
	<DOCNO>NCT01040559</DOCNO>
	<brief_summary>The purpose study determine maximal tolerate dose idarubicin chemoembolization non resectable non metastatic hepatocellular carcinoma .</brief_summary>
	<brief_title>Chemoembolisation Non Resectable , Non Metastatic Hepatocellular Carcinomas</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) fifth common malignancy third common cause cancer-related death worldwide . Most patient diagnose intermediate-advanced stage sole standard treatment transarterial chemoembolization ( TACE ) . In literature , survival rate TACE study vary widely finally , suggestion best chemotherapeutic agent optimal treatment regimen . We hypothesise use idarubicin ( cytotoxic drug HCC cell line ) DC Bead would enhance efficacy TACE . The primary objective study determine maximal tolerate dose idarubicin DC Bead chemoembolization non resectable non metastatic hepatocellular carcinoma .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Idarubicin</mesh_term>
	<criteria>Hepatocellular carcinoma cytologically histologically prove diagnosed accord criterion American Association Study Liver Diseases ( AASLD 2005 ) Three nodule maximum ( unilobar disease without limitation number nodule ; 3 maximum nodule bilobar disease [ satellite nodule &lt; 1cm include total sum ] ) ChildPugh score A B7 ECOG Performance Status &lt; 2 Platelet count &gt; 50,000/µl absolute neutrophil count ( ANC ) &gt; 1,000/µl Serum creatinine &lt; 150 µmol/l Resting ejection fraction &gt; 50 % ( echocardiography isotopic method ) Age &gt; 18 year Signed write informed consent Patients eligible surgical resection hepatic transplantation radiofrequency ablation Extrahepatic metastasis Known gastrointestinal bleeding 30 day study entry Patients anticoagulant treatment Evidence portal vein thrombosis Pregnancy Clinically serious infection Known hypersensitivity anthracyclines Known hypersensitivity contrast medium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>